Tag: drugs

Understanding these dynamics is pivotal for promoting informed decision-making and improving patient outcomes in medication management, according to the survey

Molecule GEN aims to significantly reduce the time and cost associated with bringing new, life-saving drugs to market

The key opinion leaders (KOL’s) interviewed by GlobalData expressed that all the available treatments, including newly approved Relyvrio and Qalsody lack efficacy in their modes of actions

The integration of AI technology into the evaluation process holds the potential to reshape the landscape of cancer clinical trials and generate more effective treatments

TPD drugs selectively target disease-causing proteins by leveraging intracellular protein degradation mechanisms

The proliferation of substandard or counterfeit drugs not only endangers public health but also obstructs the nation’s economic development, writes Mandeep Singh, Executive Director, Torque Pharmaceuticals

SATB is urging swift and immediate action from the Ministry of Health and Family Welfare to resolve this situation

The current issue discusses both approved and pending bills related to bioscience sector in the Parliament. It features the power-packed interviews with Krishna Mohan Puvvada, Vice President, Novozymes-South Asia; Dr Radha Rangarajan, Director, Central Drug Research Institute; Vikram Thaploo, CEO-Telehealth, Apollo Hospitals; and Vaibhav Tewari, Co-founder & CEO, Portea Medical.

The demand for high content screening is projected to surge with a projected CAGR of 5.8%

In a highly informative conversation, Dr Kanury V S Rao, Co-Founder & Chief Scientific Officer, PredOmix spoke to Rahul Koul, Chief Editor, BioVoice News...